Immunologic and respiratory responses to airway challenges of dogs with toluene diisocyanate
- PMID: 6304178
- DOI: 10.1016/0091-6749(83)90443-8
Immunologic and respiratory responses to airway challenges of dogs with toluene diisocyanate
Abstract
Dogs received biweekly or monthly aerosol immunization with single doses of toluene diisocyanate (TDI) that were cumulative doses analogous to human chronic exposure at 0.02 ppm. The three dogs developed systemic immune responses to TDI-dog serum albumin (DSA). The immune responses included IgG, IgA, and IgM antibody responses and development of lymphocyte reactivity. IgA titers approached IgG titers and both were persistent, whereas IgM titers were low and of short duration. IgE antibody titers demonstrated by endpoint cutaneous titration appeared but fluctuated and became negative in spite of continued aerosol exposure of TDI. Immediate-type airway responses occurred after TDI aerosolization. Some limited responses that showed only abnormalities of selected pulmonary function parameters were clearly not immunologically mediated because they occurred with initial exposure. Other immediate-type airway responses occurred that qualitatively simulated IgE-mediated, antigen-induced airway responses in dogs. There was a statistically significant correlation (p = 0.0268) between these latter airway responses and immediate-type skin reactivity. This study demonstrates that this dog model simulates the complexity of airway responses to TDI in man but may provide a laboratory system for evaluation of immunologic or other proposed mechanisms of TDI asthma.
Similar articles
-
Toluene diisocyanate-induced airway hyperreactivity and pathology in the guinea pig.J Allergy Clin Immunol. 1986 Jun;77(6):828-34. doi: 10.1016/0091-6749(86)90380-5. J Allergy Clin Immunol. 1986. PMID: 3011873
-
Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate-human serum albumin conjugate: useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma.Clin Exp Allergy. 2002 Apr;32(4):551-5. doi: 10.1046/j.0954-7894.2002.01349.x. Clin Exp Allergy. 2002. PMID: 11972601
-
Specific IgG, but not specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results.J Allergy Clin Immunol. 1999 Oct;104(4 Pt 1):847-51. doi: 10.1016/s0091-6749(99)70297-6. J Allergy Clin Immunol. 1999. PMID: 10518831
-
Recent developments in diisocyanate asthma.Curr Opin Allergy Clin Immunol. 2001 Apr;1(2):169-75. doi: 10.1097/01.all.0000011003.36723.d8. Curr Opin Allergy Clin Immunol. 2001. PMID: 11964686 Review.
-
The development of an animal model for TDI asthma.Bull Eur Physiopathol Respir. 1987 Nov-Dec;23(6):571-6. Bull Eur Physiopathol Respir. 1987. PMID: 2456109 Review.
Cited by
-
Respiratory and other hazards of isocyanates.Int Arch Occup Environ Health. 1994;66(3):141-52. doi: 10.1007/BF00380772. Int Arch Occup Environ Health. 1994. PMID: 7814092 Review.
-
Occupational lung disease induced by reactive chemicals.Clin Rev Allergy. 1985 May;3(2):217-26. doi: 10.1007/BF02992984. Clin Rev Allergy. 1985. PMID: 3986735 No abstract available.
-
Immune sensitization to methylene diphenyl diisocyanate (MDI) resulting from skin exposure: albumin as a carrier protein connecting skin exposure to subsequent respiratory responses.J Occup Med Toxicol. 2011 Mar 17;6:6. doi: 10.1186/1745-6673-6-6. J Occup Med Toxicol. 2011. PMID: 21414210 Free PMC article.
-
In vivo models of occupational asthma due to low molecular weight chemicals.Occup Environ Med. 1995 Aug;52(8):539-43. doi: 10.1136/oem.52.8.539. Occup Environ Med. 1995. PMID: 7663640 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous